These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 12134540)

  • 1. [Hypertension and endothelial dysfunction].
    Zoghi M; Nalbantgil I
    Anadolu Kardiyol Derg; 2002 Jun; 2(2):142-7, AXVIII. PubMed ID: 12134540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rationale for treatment of endothelial dysfunction in hypertension.
    Ruschitzka F; Corti R; Noll G; Lüscher TF
    J Hypertens Suppl; 1999 Feb; 17(1):S25-35. PubMed ID: 10340841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting endothelial dysfunction in hypertensive subjects.
    Thuillez C; Richard V
    J Hum Hypertens; 2005 Jun; 19 Suppl 1():S21-5. PubMed ID: 16075029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial dysfunction in essential hypertension.
    Panza JA
    Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-26-33. PubMed ID: 9422849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nebivolol on blood oxygen transport indices and endothelial dysfunction in patients with arterial hypertension.
    Pronko TP; Zinchuk VV
    Clin Physiol Funct Imaging; 2009 May; 29(3):170-6. PubMed ID: 19170724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial dysfunction: its pathogenic role in atherosclerosis and its reversal by ACE inhibition.
    Neutel JM
    Postgrad Med; 2000 Oct; 108(5 Suppl):4-11. PubMed ID: 19667535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function.
    Morimoto S; Maki K; Aota Y; Sakuma T; Iwasaka T
    Hypertens Res; 2008 Aug; 31(8):1603-10. PubMed ID: 18971536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium channel blockers, endothelial dysfunction, and combination therapy.
    Schulman IH; Zachariah M; Raij L
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):40-5. PubMed ID: 16640172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the renin-angiotensin system in vascular health: use of ACE inhibition to improve vascular function.
    Izzo JL
    Heart Dis; 2000; 2(5):380-3. PubMed ID: 11728286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive evaluation of endothelial function.
    Bae JH
    J Cardiol; 2001; 37 Suppl 1():89-92. PubMed ID: 11433834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of endothelial dysfunction in the pathogenesis and in clinical practice of atherosclerosis. Current evidences].
    Patti G; Melfi R; Di Sciascio G
    Recenti Prog Med; 2005 Oct; 96(10):499-507. PubMed ID: 16491775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ACE inhibition and AT1-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients.
    Yavuz D; Koç M; Toprak A; Akpinar I; Velioğlu A; Deyneli O; Haklar G; Akalin S
    J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):197-203. PubMed ID: 14608527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure.
    Yamamoto E; Kataoka K; Shintaku H; Yamashita T; Tokutomi Y; Dong YF; Matsuba S; Ichijo H; Ogawa H; Kim-Mitsuyama S
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2569-75. PubMed ID: 17932313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Participation of endothelium-derived vasoconstrictor factors in arterial hypertension].
    Lahera V; Navarro-Cid J; Maeso R; Cachofeiro V
    Rev Esp Cardiol; 1999; 52 Suppl 3():4-11. PubMed ID: 10614144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endothelial dysfunction in hypertension--clinical implications].
    Kosmala W
    Pol Merkur Lekarski; 2002 Apr; 12(70):333-5. PubMed ID: 12089901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Endothelial dysfunction].
    Nagy J; Csiky B; Kovács T; Wittmann I
    Orv Hetil; 2001 Aug; 142(31):1667-72. PubMed ID: 11556260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of long-term antihypertensive therapy on vaso-regulating function of the brachial artery in patients with arterial hypertension associated with type 2 diabetes mellitus].
    Karpov RS; Koshel'skaia OA; Fal'kovskaia AIu; Ocheredko NA; Atroshenkov AV; Makarova EV
    Ter Arkh; 2003; 75(11):56-60. PubMed ID: 14708444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between nitric oxide and angiotensin II in the endothelium: role in atherosclerosis and hypertension.
    Schulman IH; Zhou MS; Raij L
    J Hypertens Suppl; 2006 Mar; 24(1):S45-50. PubMed ID: 16601573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the multidrug resistance protein-1 in hypertension and vascular dysfunction caused by angiotensin II.
    Widder JD; Guzik TJ; Mueller CF; Clempus RE; Schmidt HH; Dikalov SI; Griendling KK; Jones DP; Harrison DG
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):762-8. PubMed ID: 17272743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial dysfunction in patients with noncomplicated and complicated hypertension.
    Goch A; Banach M; Mikhailidis DP; Rysz J; Goch JH
    Clin Exp Hypertens; 2009 Feb; 31(1):20-30. PubMed ID: 19172456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.